A Registered Cohort Study on Cerebellar Ataxia in the Organization in South-East China for Cerebellar Ataxia Research (OSCCAR)
1 other identifier
observational
1,500
1 country
1
Brief Summary
Cerebellar ataxia is a form of ataxia originating in the cerebellum. Cerebellar ataxia can occur as a result of many diseases and may present with symptoms of an inability to coordinate balance, gait, extremity and eye movements. To understand the clinical and genetic characteristics of cerebellar ataxia, we establish a registered cohort to follow up Chinese patients with cerebellar ataxia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2019
CompletedFirst Submitted
Initial submission to the registry
July 4, 2019
CompletedFirst Posted
Study publicly available on registry
July 8, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2039
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2059
July 12, 2023
July 1, 2023
20.4 years
July 4, 2019
July 11, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
The incidence of hereditary cerebellar ataxia
Look for the causative gene in the patient with cerebellar ataxia
Up to 20years
Interventions
No intervention
Eligibility Criteria
Patients with cerebellar ataxia who are diagnosed by tow neurologists in the Organization in South-East China for Cerebellar Ataxia Research (OSCCAR) from the First Affiliated Hospital of Fujian Medical University.
You may qualify if:
- Patients with cerebellar ataxia based on the diagnoses of tow neurologists
- Relatives of patients with cerebellar ataxia
- Unrelated healthy controls
- Participants or legal guardian(s) willing and able to complete the informed consent process
You may not qualify if:
- Participants are unable to comply with trial procedures and visit schedule
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Neurology ,First Affiliated Hospital Fujian Medical University
Fuzhou, Fujian, 350005, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- The Vice President
Study Record Dates
First Submitted
July 4, 2019
First Posted
July 8, 2019
Study Start
July 1, 2019
Primary Completion (Estimated)
December 1, 2039
Study Completion (Estimated)
December 1, 2059
Last Updated
July 12, 2023
Record last verified: 2023-07